CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
False
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
August 14, 2026
4 min read
John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors
August 14, 2026
0 min read
Why effective study training depends on relevance, timing, and oversight.
August 13, 2026
8 min read
Alexander Seyf on why the UK is losing ground in cell and gene therapy, the real bottlenecks to commercialization, and why digitalization is no longer optional
August 6, 2026
8 min read
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades
False
Affiliations:
Specialties:
Areas of Expertise: